Positron Emission Tomography in the Neuroimaging of Autism Spectrum Disorder: A Review
Authors:
Open Access
- 13 April 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 16, 806876
Abstract
Autism spectrum disorder (ASD) is a basket term for neurodevelopmental disorders characterized by marked impairments in social interactions, repetitive and stereotypical behaviors, and restricted interests and activities. Subtypes include (A) disorders with known genetic abnormalities including fragile X syndrome, Rett syndrome, and tuberous sclerosis and (B) idiopathic ASD, conditions with unknown etiologies. Positron emission tomography (PET) is a molecular imaging technology that can be utilizedin vivofor dynamic and quantitative research, and is a valuable tool for exploring pathophysiological mechanisms, evaluating therapeutic efficacy, and accelerating drug development in ASD. Recently, several imaging studies on ASD have been published and physiological changes during ASD progression was disclosed by PET. This paper reviews the specific radioligands for PET imaging of critical biomarkers in ASD, and summarizes and discusses the similar and different discoveries in outcomes of previous studies. It is of great importance to identify general physiological changes in cerebral glucose metabolism, cerebral blood flow perfusion, abnormalities in neurotransmitter systems, and inflammation in the central nervous system in ASD, which may provide excellent points for further ASD research.Keywords
Funding Information
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
This publication has 184 references indexed in Scilit:
- Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept StudyStem Cells International, 2013
- Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imagingBioorganic & Medicinal Chemistry, 2012
- The 5-HT 2A receptor and serotonin transporter in Asperger's Disorder: A PET study with [ 11 C]MDL 100907 and [ 11 C]DASBPsychiatry Research: Neuroimaging, 2011
- An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28Journal of Cerebral Blood Flow & Metabolism, 2011
- Alterations of GABAergic Signaling in Autism Spectrum DisordersNeural Plasticity, 2011
- Brief Report: The Dopamine-3-Receptor Gene (DRD3) is Associated with Specific Repetitive Behavior in Autism Spectrum Disorder (ASD)Journal of Autism and Developmental Disorders, 2011
- Two Binding Sites for [3H]PBR28 in Human Brain: Implications for TSPO PET Imaging of NeuroinflammationJournal of Cerebral Blood Flow & Metabolism, 2010
- Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autismAutism Research, 2009
- Serotonin and dopamine transporter binding in children with autism determined by SPECTDevelopmental Medicine & Child Neurology, 2008
- Studies on 5-hydroxyindole metabolism in autistic and other mentally retarded childrenThe Journal of Pediatrics, 1961